Calvin Roberson Jr. was named operations director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s Office of Community Outreach and Engagement.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
